Federal regulators have warned the maker of Ozempic and Wegovy that it failed to report possible drug side effects to the government.

GLP-1 receptor agonist therapy for type 2 diabetes or obesity is associated with a significantly lower risk of developing colon cancer.

GLP-1RAs are associated with greater annualized total hip bone loss in patients without diabetes, driven primarily by weight loss.

The guidelines prioritize earlier lifestyle interventions for the prevention of atherosclerotic cardiovascular disease.

Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...

In patients with diabetes and multivessel CAD, ticagrelor fails to meet noninferiority criteria compared with prasugrel at 1-year post-PCI.

The new guidance includes recommendations for MRI and transvaginal ultrasonography in the evaluation of suspected endometriosis.

Patients with HCM living either in an area with lower median household income or worse SDI are more likely to experience adverse outcomes ...

The multidisciplinary team (MDT) model was an essential component of providing patient-centered, personalized care for thyroid cancer.

Although the Graves disease treatment landscape remains challenging, emerging therapies could shift existing treatment ...

Deaths linked to pregnancy and childbirth fell slightly in the United States in 2024, according to a new study.

Topline data were announced from a phase 3 trial evaluating DTX301 (avalotcagene ontaparvovec) for the treatment of OTC deficiency.